enow.com Web Search

  1. Ads

    related to: sglt-2 diabetes medication
    • Cardiovascular Risk

      Learn About The Connection Between

      Type 2 Diabetes & CV Risk

    • How It Works

      Manage Your A1C And Type 2 Diabetes

      Discover A Treatment Option

    • Savings Card

      Are You Eligible For Savings?

      See If You Qualify Here.

    • Patient Support

      Get A Free 30 Minute Consultation

      With A Certified Diabetes Educator

Search results

  1. Results from the WOW.Com Content Network
  2. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]

  3. Type 2 diabetes drugs could lower dementia, Parkinson's ... - AOL

    www.aol.com/type-2-drugs-could-lower-133000670.html

    The analysis showed that over a follow-up period of an average of 2.06 years for people on SGLT2 inhibitors, and 3.70 years for people on different antidiabetes drugs, there was a reduction in the ...

  4. A Common Drug Could Lower Your Dementia Risk By 35 ... - AOL

    www.aol.com/common-drug-could-lower-dementia...

    SGLT-2 inhibitors are a class of medications that treat type 2 diabetes. The medications help keep the kidneys from reabsorbing too much glucose and allow you to pee it out instead of circulating ...

  5. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    SGLT2 inhibition: Inhibition of sodium-glucose transport protein 2 (SGLT2) ... Metformin is a first-line medication used for treatment of type 2 diabetes. It is ...

  6. Discovery and development of gliflozins - Wikipedia

    en.wikipedia.org/wiki/Discovery_and_development...

    Gliflozins are a class of drugs in the treatment of type 2 diabetes (T2D). They act by inhibiting sodium/glucose cotransporter 2 (SGLT-2), and are therefore also called SGLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents glucose from going into blood circulation by promoting glucosuria .

  7. Type 2 drugs could lower dementia, Parkison's disease risk - AOL

    www.aol.com/type-2-drugs-could-lower-133000359.html

    The analysis showed that over a follow-up period of an average of 2.06 years for people on SGLT2 inhibitors, and 3.70 years for people on different antidiabetes drugs, there was a reduction in the ...

  1. Ads

    related to: sglt-2 diabetes medication